Enovis ENOV
NYSE ENOV
$18.61 -0.42 (-2.21%)
As of: Sep 10, 2026 · 12:35 PM EDT

Enovis (ENOV) Divestments (2025)

Enovis' (ENOV) quarterly Divestments came in at $43.3 million in Q4 2025, up 2604.56% quarter-over-quarter from $1.6 million in Q2 2025.

Analysis

Enovis (ENOV) Divestments (2025) Analysis & Trends

Enovis (ENOV) has reported Divestments for 1 consecutive years, with $43.3 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to $43.3 million in Q4 2025; TTM through Dec 2025 was $44.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $43.3 million, changed N/A from the prior year.
  • Divestments was $43.3 million for Q4 2025 at Enovis, up from $1.6 million in the prior quarter.
  • Over five years, Divestments peaked at $43.3 million in Q4 2025 and troughed at $1.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn -
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn -
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn -
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn -
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 43.30 Mn
Apr 4, 2025 1.60 Mn